Amnionmembrantransplantation und hoch dosiertes systemisches Ciclosporin A (Sandimmun optoral®) bei Ulkus Mooren

Autor:	R Sundmacher, H Spelsberg
Rok vydání:	2007
Předmět:	medicine.medical_specialty Visual acuity business.industry Inflammation corneal ulcer medicine.disease Marginal Ulcer Surgery Transplantation Ophthalmology Cyclosporin a medicine medicine.symptom business Wound healing Mooren's ulcer
Zdroj:	Klinische Monatsblätter für Augenheilkunde. 224:135-139
ISSN:	1439-3999 0023-2165
DOI:	10.1055/s-2006-927400
Popis:	BACKGROUND: Mooren's ulcer is a rare, severe corneal autoimmune inflammation leading to blindness if treated insufficiently. High-dose systemic cyclosporin A (Sandimmun optoral) was shown to markedly reduce inflammation and stop corneal destruction. We report on three cases in which this immunosuppressive regimen required additional AM transplantation for complete healing. PATIENTS: One 37-year-old male (M) and two 49- (F1) and 58-year-old females (F2) presented with unilateral Mooren's ulcer in different stages of the disease, which deteriorated despite high-dose systemic cyclosporin A (Sandimmun optoral M, F1) or treatment with topical cyclosporin A 2 % (F2). After surgical removal of all grossly affected corneal stroma, amniotic membrane was made to cover the entire cornea and fixed with episcleral sutures in two patients (M, F2). In one patient (F1) a deep marginal ulcer was covered with a fitted AM glap. All patients were treated postoperatively up to 6 months with high-dose systemic cyclosporin A (Sandimmun optoral). Blood trough levels aimed at 150 to 200 ng/mL. Topical cyclosporin A was administered in addition in two patients (M, F2) postoperatively for at least 6 months. Due to incompatibility, one patient (F1) was treated with topical steroids instead. RESULTS: Follow-up time was 42 months (M), 50 months (F1) and 54 months (F2). All three eyes exhibited clinical healing with stable corneal surfaces thereafter. Depending on the stage of Mooren's ulcer at the time of surgery, visual acuity remained at hand motions in one patient (M) and recovered to 1.0 and 0.6, respectively, in two patients (F1, F2). CONCLUSION: Due to its anti-inflammatory potential, coverage by AM seems to trigger a therapeutic turnaround in cases of Mooren's ulcer which do not heal with intensive immunosuppressive regimens alone. In order to maintain or restore as much visual function as possible, additional amniotic membrane surgery should be performed early enough in the course of the disease.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8b38aacfb658dc5e77e3f9c8e07a87e3 https://doi.org/10.1055/s-2006-927400 Zobrazit plný text záznamu